Director - Global Commercial Planning and Forecasting
Alvotech
Director - Global Commercial Planning and Forecasting
Alvotech
Develops, manufactures biosimilars for global markets
Alvotech is seeking an experienced Director of Global Commercial Planning & Forecasting to strengthen commercial planning, forecasting, and strategic decision-making across its global biosimilars portfolio.
The successful candidate will play a central role in evaluating and integrating forecasts from global commercialization partners, supporting commercially and financially optimized supply allocation decisions, and developing forecasts and business cases for new business development opportunities.
This position requires strong analytical capabilities, sound commercial judgment, and the ability to work across global markets, external partners, and internal commercial, supply chain, finance, and business development functions.
The ideal candidate will bring 10–15 years of relevant pharmaceutical industry experience, preferably within generics, biosimilars, specialty pharmaceuticals, or B2B pharmaceutical commercialization.
Key Responsibilities
The ideal candidate combines strong pharmaceutical commercial knowledge with exceptional analytical and problem-solving capabilities.
They should be comfortable challenging partner assumptions, developing independent forecasts, evaluating competing commercial priorities, and building financially credible business cases.
Importantly, this individual must be able to look beyond the numbers to understand the underlying commercial realities, identify trade-offs, and provide practical recommendations that improve business outcomes.
The role requires someone who can operate effectively across global markets, influence cross-functional stakeholders, and support senior commercial leadership in making complex decisions.
Within the first 12 months, the successful candidate will have:
Alvotech develops and manufactures biosimilar medicines, which are lower-cost versions of biologic drugs used to treat a range of diseases. Its biosimilars are produced through a vertically integrated process, controlling cell line development, manufacturing, and final product steps to ensure quality and efficiency. The company differentiates itself by owning and coordinating the full value chain, enabling tighter cost control, scalable production, and faster delivery of biosimilars to global markets. Alvotech aims to improve lives by making biologic medicines more accessible and affordable, continually evaluating new pipeline opportunities to expand its portfolio and revenue streams.
Explore more opportunities at Alvotech